Zelta ranked as a Leader in Everest Group’s 2024 EDC Products PEAK® Matrix Assessment
We’re excited to announce that Zelta has been officially ranked as a Leader in the Everest Group’s inaugural 2024 EDC Products PEAK® Matrix Assessment!
This recognition builds off of our placement in another Everest Group PEAK Matrix® report last year as a Major Contender, and follows a year of momentum that saw the Zelta platform surpass 4,200 clinical trial studies. The Leader recognition validates our longevity and track record in the clinical trials market – while our brand name may be relatively new, our clinical solutions have been leading the market for over a decade, with support for over 500 phase III trials, executed in over 100 countries around the world.
"Zelta EDC offers a highly configurable, low-code platform that simplifies operations and integrates seamlessly with clinical systems like CTMS, RTSM, and IRT. The platform is valued for its modular offerings and competitive pricing. Zelta's strengths in client-centric support, project management, and quick query resolution have positioned Zelta (Merative) as a Leader in Everest Group’s Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix® Assessment 2024."
– Nisarg Shah, Practice Director, Everest Group
Everest Group evaluated the offerings of 20 market-leading EDC providers. Zelta was one of just five providers to be officially placed in the Leader category, a category defined as solution providers who “demonstrate comprehensive EDC capabilities – data ingestion, study design, mid-study changes, data management, review, and reporting.”
Everest Group identifies Leaders like Zelta as solutions that:
- Offer all-encompassing EDC solution capabilities
- Boast AI and ML investments that “enhance EDC capabilities such as protocol generation, data extraction, remote SDV automation, and AI-based query management and anomaly detection.”
- Most of the leaders excel in native SDTM transformation capabilities, providing seamless data ingestion.
- Clients value these solutions for their user-friendly design and low-code functionalities, “enabling smooth operations with minimal/no technical and programming skills.”
Why choose Zelta for your clinical studies
In explaining their decision to rank Zelta as a Leader, Everest Group highlighted the following on why the Zelta EDC platform has been recognized:
- Zelta “is a highly configurable and easy-to-use platform,” with a low-code solution that lowers the barrier to entry for users.
- EDC integration capabilities like CTMS, RTSM, and IRTs, make the platform a flexible, adaptable choice.
- Zelta has developed an extensive partnership network, collaborating with “CTMS, RTSM, clinical suppliers providers, service providers, healthcare payers, providers, and payment technology providers” to provide multiple options for users to choose from.
- A combination of modular offerings, competitive pricing, and a client-centric approach to active support, project management, and query resolution makes the platform a popular choice among users.
“I’m incredibly proud of the work we do, and the Everest Group’s ranking of Zelta as a Leader reflects our continued commitment and ability to accelerate clinical trials with control and confidence with our best-in-class solutions.”
– Jennifer Duff, General Manager, Zelta by Merative
Zelta users in action
Zelta is trusted by over 200 CROs, sponsors, med device and biopharma companies worldwide. Our users aren’t just customers, they’re strategic partners, whose participation in our user forum and at our annual user conferences provides direct, in-person feedback to help shape the future of the Zelta solutions roadmap.
“Through this partnership with Zelta and with the familiarity of many years of work, the channels of communication between us are streamlined. We can provide feedback and advance the Zelta product so it can better support our work. The Zelta team are very efficient at addressing questions, and that willingness to collaborate is super important to us as we are always under high pressure to deliver.”
-- Nan Shao, Executive Vice President of Global Operations, Veristat
Want to know more about what makes Zelta a Leader, and how the platform has helped CROs, sponsors, med device and biopharma companies accelerate their clinical trials with control and confidence?
Read about how Veristat, the global Science-First™ CRO, cut gene therapy trial database costs by 30% thanks to more efficient data management support by Zelta.
“The Zelta support team is great. They get to us very quickly. I can reach out to my sales rep and they will get back to me immediately as well with any support issues. If I'm having trouble going live or anything like that, they will immediately get back to me.”
--Katrina Riggs, Chief Operating Officer, Fast-Track Drugs and Biologics
Watch Fast-Track's Zelta story
“Using AI in our medical coding, we can get through the volume more quickly but also more intelligently.”
– David Provenghi, Director of Clinical Data Management, ProSciento
Find out how ProSciento used Zelta to empower their medical coders with faster and more precise medical coding.
Now try it for yourself. Get a firsthand look with our interactive demo to see how building a study in Zelta is easier than ever.